登录后 PLUS 会员 可查看完整内容
微信扫一扫
成为会员后
查看完整内容
1. CatapanoAL, ReinerZ, De BackerG, et al. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) [J]. Atherosclerosis, 2011, 217(1):3-46.
2. RubinsHB, RobinsSJ, CollinsD, et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group[J]. N Engl J Med, 1999, 341(6):410-418.
3. MesserliFH, BangaloreS, RamVS. Telmisartan, ramipril, or both in patients at high risk of vascular events[J]. N Engl J Med, 2008, 359(4):426-427.
感谢以下医疗从业者参与贡献
排序不分先后